GRAIL Inc (GRAL) ニュース

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire MENLO PARK, Calif., Dec. 18...

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., Dec. 3...

Form 4 - Statement of changes in beneficial ownership of securities

GRAIL to Participate in Upcoming Investor Conferences

GRAIL to Participate in Upcoming Investor Conferences PR Newswire MENLO PARK, Calif., Nov. 19, 2024 MENLO...

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study PR...

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

GRAIL Reports Third Quarter 2024 Financial Results

GRAIL Reports Third Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., Nov. 12, 2024 Galleri...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR...

Form 4 - Statement of changes in beneficial ownership of securities

GRAIL to Announce Third Quarter 2024 Financial Results

GRAIL to Announce Third Quarter 2024 Financial Results PR Newswire MENLO PARK, Calif., Oct. 29, 2024 MENLO...

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early...

Form 3 - Initial statement of beneficial ownership of securities